Showing results (321-330 of 403) with videos related to

Sort By:
Pageof 41
Diabetes, Obesity & Metabolism|March 13, 2026
An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementationSufyan Hussain, Timothy Tree, Chantal Mathieu, et al.
Expert Opinion on Pharmacotherapy|October 30, 2015
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenibAndrea Casadei Gardini, Giorgia Marisi, Emanuela Scarpi, et al.
Lung Cancer (Auckland, N.Z.)|July 4, 2025
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma PatientsMatteo Canale, Alessandra Virga, Davide Angeli, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric CancerGianluca Tedaldi, Chiara Molinari, Celina São José, et al.
Frontiers in Immunology|February 25, 2025
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapyAnna De Lucia, Lucia Mazzotti, Anna Gaimari, et al.
Neoplasia (New York, N.Y.)|July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma CellsMara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
The Oncologist|May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancerVincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
Cancers|September 14, 2019
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer PredispositionGianluca Tedaldi, Francesca Pirini, Michela Tebaldi, et al.
Pflugers Archiv : European Journal of Physiology|December 5, 2016
Common variants in CLDN14 are associated with differential excretion of magnesium over calcium in urineTanguy Corre, Eric Olinger, Sarah E Harris, et al.
Targeted Oncology|November 10, 2020
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 StudyLuca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Pageof 41